Abstract:Germline mutations in the folliculin (FLCN) tumor suppressor gene are linked to Birt-Hogg-Dubé (BHD) syndrome, a dominantly inherited genetic disease characterized by predisposition to fibrofolliculomas, lung cysts, and renal cancer. Most BHD-linked FLCN variants include large deletions and splice site aberrations predicted to cause loss of function. The mechanisms by which missense variants and short in-frame deletions in FLCN trigger disease are unknown. Here, we present an integrated computational and experimental study that reveals that the majority of such disease-causing FLCN variants cause loss of function due to proteasomal degradation of the encoded FLCN protein, rather than directly ablating FLCN function. Accordingly, several different single-site FLCN variants are present at strongly reduced levels in cells. In line with our finding that FLCN variants are protein quality control targets, several are also highly insoluble and fail to associate with the FLCN-binding partners FNIP1 and FNIP2. The lack of FLCN binding leads to rapid proteasomal degradation of FNIP1 and FNIP2. Half of the tested FLCN variants are mislocalized in cells, and one variant (ΔE510) forms perinuclear protein aggregates. A yeast-based stability screen revealed that the deubiquitylating enzyme Ubp15/USP7 and molecular chaperones regulate the turnover of the FLCN variants. Lowering the temperature led to a stabilization of two FLCN missense proteins, and for one (R362C), function was re-established at low temperature. In conclusion, we propose that most BHD-linked FLCN missense variants and small in-frame deletions operate by causing misfolding and degradation of the FLCN protein, and that stabilization and resulting restoration of function may hold therapeutic potential of certain disease-linked variants. Our computational saturation scan encompassing both missense variants and single site deletions in FLCN may allow classification of rare FLCN variants of uncertain clinical significance.

Detection of Folliculin Gene Mutations in Two Chinese Families with Birt-Hogg-Dube Syndrome.

Novel Germline Mutations in FLCN Gene Identified in Two Chinese Patients with Birt–Hogg–Dubé Syndrome

Progress in diagnosis and treatment of Birt-Hogg-Dubé syndrome

Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.

A splicing mutation of the FLCN gene is associated with Birt-Hogg-Dubé syndrome characterized by familial and recurrent spontaneous pneumothorax: A case report

Birt-Hogg-Dube syndrome with c.1579_1580insA variant in a Chinese family: a case report

Clinical relevance of FLCN mutations in Asian patients with Birt-Hogg-Dube syndrome

Guiding the future of clinical care and clinical research in Birt-Hogg-Dubé

Birt-Hogg-Dubé Syndrome in Two Chinese Families with Mutations in the FLCN Gene

Genetic screening of the FLCN gene identify six novel variants and a Danish founder mutation

The Clinical Characteristics of East Asian Patients with Birt-Hogg-Dubé Syndrome

Bilateral Periventricular Nodular Heterotopia Caused By A Novel Splicing Mutation In The Flna Gene In A Chinese Family

A Novel FLCN Intragenic Deletion Identified by NGS in a BHDS Family and Literature Review

Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report

New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome

A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions

Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation

Lymphoplasmacytic lymphoma in a patient with Birt–Hogg–Dubé syndrome

AB111. Features of Birt-Hogg-Dubé Syndrome Patients in East Asian Countries

Flcn-Regulated Mirnas Suppressed Reparative Response In Cells And Pulmonary Lesions Of Birt-Hogg-Dube Syndrome

Familial spontaneous pneumothorax: importance of screening for Birt-Hogg-Dubé syndrome.